Clinical Trial Update: STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma [Phase 3]

View source ↗

Summary

Phase IIIb trial update for benralizumab as step-down maintenance therapy in severe eosinophilic asthma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Eosinophilic Asthma | Phase 3 | Status: ACTIVE_NOT_RECRUITING